Lista de obras -

A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin.

artículo científico publicado en 2008

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding

scientific article published on 19 September 2016

Challenging resistance mechanisms to therapies for metastatic melanoma.

artículo científico publicado en 2013

Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin.

artículo científico publicado en 2014

Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes

artículo científico publicado en 2000

Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth

artículo científico publicado en 2016

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid

scientific article published on 14 November 2018

Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression.

artículo científico publicado en 2011

Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth

scientific journal article

Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion

artículo científico publicado en 2013

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

artículo científico publicado en 2006

Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.

artículo científico publicado en 2013

Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide

artículo científico publicado en 1997

Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide.

artículo científico publicado en 2008

MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.

artículo científico publicado en 2013

Multiple Sclerosis Treatment and Melanoma Development

scientific article published on 22 April 2020

Neuropilin-1 as Therapeutic Target for Malignant Melanoma.

artículo científico

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma.

artículo científico publicado en 2015

Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms.

artículo científico publicado en 2013

On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment

artículo científico publicado en 2019

PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation

artículo científico publicado en 2020

Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells.

artículo científico publicado en 2009

Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.

artículo científico publicado en 2013

Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.

artículo científico publicado en 2016

Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.

artículo científico publicado en 2013

Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide

artículo científico publicado en 2005

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis

article

Poly(ADP-ribose) polymerase inhibitor olaparib hampers placental growth factor-driven activation of myelomonocytic cells.

artículo científico publicado en 2018

Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo.

artículo científico publicado en 2017

Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma

artículo científico publicado en 2020

Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor

artículo científico publicado en 2016

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.

artículo científico publicado en 2017

Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes.

artículo científico publicado en 2004

The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.

artículo científico publicado en 2017

The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells

artículo científico publicado en 2017

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.

artículo científico publicado en 2018

Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors

artículo científico publicado en 2018

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

artículo científico publicado en 2014

Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.

artículo científico publicado en 2003

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

artículo científico publicado en 2019

Lista de obras de

A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin.

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding

Challenging resistance mechanisms to therapies for metastatic melanoma.

Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin.

Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes

Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid

Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression.

Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth

Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.

Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide

Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide.

MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.

Multiple Sclerosis Treatment and Melanoma Development

Neuropilin-1 as Therapeutic Target for Malignant Melanoma.

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma.

Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms.

On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment

PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation

Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells.

Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1.

Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.

Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.

Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis

Poly(ADP-ribose) polymerase inhibitor olaparib hampers placental growth factor-driven activation of myelomonocytic cells.

Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo.

Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma

Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.

Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes.

The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.

The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.

Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors

Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.

Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A